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Periodontal conditions and systemic diseases influence each 
other. The most investigated conditions are cardiovascular 
diseases, rheumatoid arthritis (RA) and diabetes mellitus (DM). 
Other studies showed relationship with hypertension, 
osteoporosis, psoriasis, pulmonary diseases, and complications 
in pregnancy and around delivery. 
The aim of our study is to evaluate the relationship between 
systemic diseases, including diabetes mellitus and rheumatoid 
arthritis, and periodontal disease (PD). We investigated the 
effect of smoking on diabetes, rheumatoid arthritis, and 
periodontal disease. 
In the literature, clear connection points can be found between 
these diseases and several articles have tried to investigate the 
effect on each other. Same mediators, factors linking diseases 
and smoking have been described: inflammatory cytokines 
(TNFα, Il-1, IL-6, IL-8, IL-12), reactive oxygen species (ROS), 
RANK/RANKL are acting bone modeling,  osteoclast activity, 
various proteolytic enzymes (MMPs) and natural killing cells 
(NKs) of lymphoid origin. 
It is obvious that inflammatory processes are performed via the 
same routes and mediators when systemic diseases we reviewed, 
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periodontal disease and smoking are present. Thus it seems clear 
that these conditions closely affect and aggravate each other. 
 
Aims of the study 
Questions regarding the RAs research: 
Can smoking play a trigger role in the development and 
exacerbation of periodontal inflammation in patients with 
rheumatoid arthritis? To test this, we measured the incidence and 
severity of periodontal inflammation in smokers and non-
smokers. 
Is there a relationship between rheumatological factors and the 
periodontal status? 
We hypothesized that the periodontal status of patients with no 
smoking history would be significantly poorer than that of 
healthy controls.  
In case of diabetes, we hypothesized that the periodontal status 
of patients with DM with no smoking history would be 
significantly poorer than that of healthy non-smoking controls, 
and the periodontal status in the former would be further 
exacerbated by smoking. 
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We aimed to find out if periodontal status is different in patients 
with type 1 and type 2 diabetes. 
 
We aimed to investiagte, the relationship between glycemic 
control and periodontal disease. 
 
Materials and Methods 
In case of RA, a total of 73 participants were enrolled into the 
study. Participants of the control group came for regular lung 
screening, and they had no systemic diseases. RA patients were 
compared to the control group. Mean age and gender frequency 
were almost equal in the two groups. 
In case of diabetes mellitus a total of 128 participants were 
included in the study, DM patients were compared to age and 
gender-matched controls. 
Smoking habits were evaluated by using a self-administered 
questionnaire. We identified non-smokers and former smokers 




We used the staging proposed by Fernandes and colleagues. 
Periodontal status of the patients was assessed by a full oral 
examination, where probing depth: PPD, bleeding on probing: 
BOP, clinical attachment loss: CAL, and the amount of plaque 
were evaluated. 
Depending on the presence and severity of periodontal disease, 
four groups were classified based on the clinical parameters 
mentioned above: healthy, early, moderate and severe 
periodontitis. 
 
From a rheumatological point of view, the following indices and 
laboratory values were recorded: IgM rheumatoid factor 
seropositivity and levels (RF), anti-citrullinated peptide 
antibody (ACPA) seropositivity, disease activity score (DAS28-
ESR), and the health assessment questionnaire disability index 
(HAQ-DI). Data on the conventional and biological disease 
modifying anti-rheumatic drug (DMARD) and corticosteroid 
therapy of the patients were also recorded. 
We investigated type 1 and type 2 diabetic patients (T1D, T2D). 
Control of diabetes was estimated by the average of the last three 
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hemoglobin A1c (HbA1c) levels. Patients were assigned into 3 
groups: well, moderately and poorly controlled. 
 
Written informed consent was obtained from each participant.  
The study was approved by the Regional Research Ethics 
Committee for Medical Research at the University of Szeged, 
Hungary (144/2014-B/001, accepted 2014, modified in 2019). 
 
Statistical analysis 
For the statistical comparison of the study and control groups, 
SPSS 21.0 (IBM, USA) was used. Continuous variables were 
described as mean ± SD, and categorical variables were 
characterized by frequency analysis. For hypothesis testing, one-
way ANOVA (with Tukey's post-hoc pairwise test), Kruskal-
Wallis ANOVA or multinomial logistic regression was used, 
depending on the sample characteristics and the hypothesis to be 
tested. The general significance limit was set at p= 0.05, but this 






Our RA study design was to identify smoking and non-smoking 
groups, but our patients turned out to be non-smokers. We 
managed to find only a few (8 in total) smoker RA patients; 
therefore, study parameters were modified. 
The majority of our patient sample consisted of non-smokers 
and former smokers.  
No significance was found in any of the rheumatological indices 
between former smoking and non-smokers. However, 
seropositivity for RF increased the odds of the moderate stage to 
1.65, and that of the severe stage to 2.51. 
The periodontal status and CAL in both control groups falls into 
the healthy and early stages, in the patient groups the situation is 
just the opposite. 
81% of the patients who used to smoke (former smokers) were 
classified as having moderate or severe PD. 
Severe periodontitis is most likely to occur in RA patients with 




In case of DM, the pairwise comparisons showed a significant 
difference in severity of PD between the smoker control and 
non-smoker control groups (p = 0.027) and between the non-
smoker control and smoker-diabetic groups (p = 0.000); the 
difference between the non-smoker diabetic and smoker diabetic 
groups was nearly significant (p = 0.052). 
The lowest frequency of severe PD was found in the non-smoker 
control group (15.6%) and was peaking in the smoker diabetic 
group (62.5%). 
No one in the two smoker groups was classified as having good 
periodontal health. 
The stages of PD followed a normal distribution in the healthy, 
non-smoking controls, smoking seemed to cause a shift toward 
the middle of the severity spectrum, and when smoking was 
combined with DM a marked shift toward the most severe stage 
was observed. 
Patients in the smoker diabetic group had significantly fewer 
teeth (mean ± SD: 16.0 ± 7.9) than subjects in the non-smoker 
control group (20.7 ± 5.6) at p = 0.02. Patients with T1D had 




There was no significant association between the type of 
diabetes (T1D or T2D) and periodontal status (χ2 = 6.190, 
p = 0.103). There was also no significant association between 
diabetes control and the severity of PD (χ2 = 15.503, p = 0.078). 
 
Discussion 
An interesting question is why we only found 8 currently smoker 
RA patients. This may be because patients are informed about 
the harmful effects of smoking that aggravate their arthritis and 
therefore quit. 
The relationship between periodontitis and rheumatoid factor 
could not be proven, perhaps due to the small number of 
elements. 
The presence of RA itself is enough to significantly increase the 
odds that the patient will develop a more severe stage of PD. In 
this term, our hypothesis was correct. 
The main finding of this study, is that the former smoker RA 
patients had the highest and significant odds ratio for the severe 
stage of PD. 
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In case of diabetes, smoking caused a shift toward the middle of 
the PD spectrum, and when smoking was combined with 
diabetes, a marked shift toward the most severe stage could be 
seen. Smoking damages periodontal tissues in both local and 
systemic ways. Smoking-induced periodontal inflammation 
always being the more severe type, while DM has a slower 
detrimental effect on the periodontium being less aggressive. 
This is supported by the fact that a smoking diabetic patient has 
significantly fewer teeth than the non-smoking control group. 
T2D may be more damaging to the periodontium than T1D, as 
reflected by the mean number of teeth and the relatively higher 
prevalence of the most severe stage in participants with T2D. A 
possible explanation for the lower teeth number in T2D is that 
T2D was over-represented, and mean the age is 14 years higher 
than in T1D. 
It would appear that there is an effect of glycemic control on PD, 
but this effect is statistically non-significant. 
The main finding is that smoking is the major detrimental factor 
for the periodontium, and if it is associated with diabetes, further 





In this thesis,  we investigated the relationship between systemic 
diseases (rheumatoid arthritis and diabetes mellitus), periodontal 
disease and smoking. Based on both studies, it can be concluded 
that the main factor, which is responsible for the aggravation of 
periodontal disease is smoking and previous smoking. However, 
it can also be stated that systemic diseases have a negative effect 
on periodontal status and its severity. It is important to 
emphasize the local and systemic harmful effects of smoking 
and to place special emphasis on the importance of smoking 
cessation. Dentists also have a great responsibility to find out 
about the patient's current general health before starting a 
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